Molecular imaging and biological evaluation of HuMV833 anti-VEGF antibody: implication for trial design of antiangiogenic antibodies

G.C. Jayson; J. Zweit; A. Jackson; C. Mulatero; P. Julyan; M. Ranson; L. Broughton; J. Wagstaff; L. Hakannson; G. Groenewegen; J. Bailey; N. Smith; D. Hastings; J. Lawrance; H. Haroon; T. Ward; A.T. McGown; M. Tang; D. Levitt; S. Marreaud; F.F. Lehmann; M. Herold; H. Zwierzina

Molecular imaging and biological evaluation of HuMV833 anti-VEGF antibody: implication for trial design of antiangiogenic antibodies

Translated title of the contribution: Molecular imaging and biological evaluation of HuMV833 anti-VEGF antibody: implication for trial design of antiangiogenic antibodies

G.C. Jayson, J. Zweit, A. Jackson, C. Mulatero, P. Julyan, M. Ranson, L. Broughton, J. Wagstaff, L. Hakannson, G. Groenewegen, J. Bailey, N. Smith, D. Hastings, J. Lawrance, H. Haroon, T. Ward, A.T. McGown, M. Tang, D. Levitt, S. MarreaudF.F. Lehmann, M. Herold, H. Zwierzina

Division Imaging & Oncology

Research output: Contribution to journal › Article › Academic › peer-review

Translated title of the contribution	Molecular imaging and biological evaluation of HuMV833 anti-VEGF antibody: implication for trial design of antiangiogenic antibodies
Original language	Undefined/Unknown
Journal	Journal of the National Cancer Institute
Volume	2;94(19)
Publication status	Published - 2002

Cite this

Jayson, G. C., Zweit, J., Jackson, A., Mulatero, C., Julyan, P., Ranson, M., Broughton, L., Wagstaff, J., Hakannson, L., Groenewegen, G., Bailey, J., Smith, N., Hastings, D., Lawrance, J., Haroon, H., Ward, T., McGown, A. T., Tang, M., Levitt, D., ... Zwierzina, H. (2002). Molecular imaging and biological evaluation of HuMV833 anti-VEGF antibody: implication for trial design of antiangiogenic antibodies. Journal of the National Cancer Institute, 2;94(19).

@article{0ff0ba5deb6c4c0ab498f218cc60aa6d,

title = "Molecular imaging and biological evaluation of HuMV833 anti-VEGF antibody: implication for trial design of antiangiogenic antibodies",

author = "G.C. Jayson and J. Zweit and A. Jackson and C. Mulatero and P. Julyan and M. Ranson and L. Broughton and J. Wagstaff and L. Hakannson and G. Groenewegen and J. Bailey and N. Smith and D. Hastings and J. Lawrance and H. Haroon and T. Ward and A.T. McGown and M. Tang and D. Levitt and S. Marreaud and F.F. Lehmann and M. Herold and H. Zwierzina",

year = "2002",

language = "Undefined/Unknown",

volume = "2;94(19)",

journal = "Journal of the National Cancer Institute",

issn = "0027-8874",

publisher = "Oxford University Press",

}

Jayson, GC, Zweit, J, Jackson, A, Mulatero, C, Julyan, P, Ranson, M, Broughton, L, Wagstaff, J, Hakannson, L, Groenewegen, G, Bailey, J, Smith, N, Hastings, D, Lawrance, J, Haroon, H, Ward, T, McGown, AT, Tang, M, Levitt, D, Marreaud, S, Lehmann, FF, Herold, M & Zwierzina, H 2002, 'Molecular imaging and biological evaluation of HuMV833 anti-VEGF antibody: implication for trial design of antiangiogenic antibodies', Journal of the National Cancer Institute, vol. 2;94(19).

TY - JOUR

T1 - Molecular imaging and biological evaluation of HuMV833 anti-VEGF antibody: implication for trial design of antiangiogenic antibodies

AU - Jayson, G.C.

AU - Zweit, J.

AU - Jackson, A.

AU - Mulatero, C.

AU - Julyan, P.

AU - Ranson, M.

AU - Broughton, L.

AU - Wagstaff, J.

AU - Hakannson, L.

AU - Groenewegen, G.

AU - Bailey, J.

AU - Smith, N.

AU - Hastings, D.

AU - Lawrance, J.

AU - Haroon, H.

AU - Ward, T.

AU - McGown, A.T.

AU - Tang, M.

AU - Levitt, D.

AU - Marreaud, S.

AU - Lehmann, F.F.

AU - Herold, M.

AU - Zwierzina, H.

PY - 2002

Y1 - 2002

M3 - Article

SN - 0027-8874

VL - 2;94(19)

JO - Journal of the National Cancer Institute

JF - Journal of the National Cancer Institute

ER -